Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Symptom persistence and recovery among COVID-19 survivors during a limited outbreak in Canterbury, New Zealand: a prospective cohort study.
Cheung J, Nordmeier K, Kelland S, Harrington M, Williman J, Storer M, Beaglehole B, Beckert L, Chambers ST, Epton MJ, Freeman J, Murdoch DR, Werno AM, Maze MJ. Cheung J, et al. Among authors: kelland s. Intern Med J. 2023 Jan;53(1):37-45. doi: 10.1111/imj.15930. Epub 2022 Sep 30. Intern Med J. 2023. PMID: 36114621 Free PMC article.
Phase 1 Combination Study of the CHK1 Inhibitor Prexasertib and the PARP Inhibitor Olaparib in High-grade Serous Ovarian Cancer and Other Solid Tumors.
Do KT, Kochupurakkal B, Kelland S, de Jonge A, Hedglin J, Powers A, Quinn N, Gannon C, Vuong L, Parmar K, Lazaro JB, D'Andrea AD, Shapiro GI. Do KT, et al. Among authors: kelland s. Clin Cancer Res. 2021 Sep 1;27(17):4710-4716. doi: 10.1158/1078-0432.CCR-21-1279. Epub 2021 Jun 15. Clin Cancer Res. 2021. PMID: 34131002 Clinical Trial.
Immune modulating activity of the CHK1 inhibitor prexasertib and anti-PD-L1 antibody LY3300054 in patients with high-grade serous ovarian cancer and other solid tumors.
Do KT, Manuszak C, Thrash E, Giobbie-Hurder A, Hu J, Kelland S, Powers A, de Jonge A, Shapiro GI, Severgnini M. Do KT, et al. Among authors: kelland s. Cancer Immunol Immunother. 2021 Oct;70(10):2991-3000. doi: 10.1007/s00262-021-02910-x. Epub 2021 Mar 20. Cancer Immunol Immunother. 2021. PMID: 33745032 Free PMC article.
Duodenal Adenomas and Cancer in MUTYH-associated Polyposis: An International Cohort Study.
Collaborative Group on Duodenal Polyposis in MAP; Thomas LE, Hurley JJ, Sanchez AA, Aznárez MR, Backman AS, Bjork J, Capella G, Clark SK, Colas C, Dekker E, Dolwani S, Ghorbanoghli Z, Gonn M, Gonzalez Romero S, Hes FJ, Jundi H, Kelland S, Latchford AR, Brito HL, Lynch PM, Meuser E, Mork ME, Mort M, Garcia MN, Nielsen M, Parc Y, Ricci MT, Saurin JC, Tuin KV, Vasen H, Vilar E, Vinet O, Vitellaro M, Walton SJ, West HD, Sampson JR. Collaborative Group on Duodenal Polyposis in MAP, et al. Among authors: kelland s. Gastroenterology. 2021 Feb;160(3):952-954.e4. doi: 10.1053/j.gastro.2020.10.038. Epub 2020 Oct 31. Gastroenterology. 2021. PMID: 33130102 Free article. No abstract available.
Past East Asian monsoon evolution controlled by paleogeography, not CO2.
Farnsworth A, Lunt DJ, Robinson SA, Valdes PJ, Roberts WHG, Clift PD, Markwick P, Su T, Wrobel N, Bragg F, Kelland SJ, Pancost RD. Farnsworth A, et al. Among authors: kelland sj. Sci Adv. 2019 Oct 30;5(10):eaax1697. doi: 10.1126/sciadv.aax1697. eCollection 2019 Oct. Sci Adv. 2019. PMID: 31692956 Free PMC article.